Stock listing
Theracryf Plc
Selected listing: 8EV · FWB · EUR · DE
Theracryf Plc (Frankfurt:8EV), Health Services. Latest release Oct 2, 2026: Australian partner to progress Ox-1 Phase 1 trial.
- Ticker
- Frankfurt:8EV
- Asset type
- Stock
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- Frankfurt
- Currency
- EUR
About Theracryf Plc
The company focuses on developing innovative solutions in its sector. Investors can find more information about its operations and performance on its dedicated corporate page.
Latest news from Theracryf Plc
Australian partner to progress Ox-1 Phase 1 trial
October 2, 2026
Posting of Annual Report and Notice of AGM
September 30, 2026
Final Results for the year ended 31 March 2026
September 28, 2026
Notice of Results and Investor Presentation
September 14, 2026
Proposed Placing & Subscription to raise £1.05m
August 20, 2026